Population pharmacokinetic analysis of doxecitine and doxribtimine in patients with thymidine kinase 2 deficiency and in healthy volunteers PAGE 33 (2025) Abstr 11353 Bouchene S, Mittur A, Naik H, Dua P, Neldemo I, Ribbing J, Bergstrand M, Khandelwal A. ConferencePharmacometricsPhase IIRare diseasesRegulatory interactions Pharmetheus Affiliates Senior Director, MIDD Consultant Ida Neldemo See bio Principal Director, MIDD Consultant & Senior Expert Jakob Ribbing See bio Principal Director, MIDD Scientific Lead Martin Bergstrand See bio
